Home LiteratureArticle Details
PMID: 10079104 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

Nucleotide pool imbalance and adenosine deaminase deficiency induce alterations of N-region insertions during V(D)J recombination.

The Journal of clinical investigation ·Vol. 103 ·No. 6 ·1999-03-00 ·Pages 833-41

Gangi-Peterson L, Sorscher DH, Reynolds JW, Kepler TB, Mitchell BS

Abstract

Template-independent nucleotide additions (N regions) generated at sites of V(D)J recombination by terminal deoxynucleotidyl transferase (TdT) increase the diversity of antigen receptors. Two inborn errors of purine metabolism, deficiencies of adenosine deaminase (ADA) and purine nucleoside phosphorylase (PNP), result in defective lymphoid development and aberrant pools of 2'-deoxynucleotides that are substrates for TdT in lymphoid precursors. We have asked whether selective increases in dATP or dGTP pools result in altered N regions in an extrachromosomal substrate transfected into T-cell or pre-B-cell lines. Exposure of the transfected cells to 2'-deoxyadenosine and an ADA inhibitor increased the dATP pool and resulted in a marked increase in A-T insertions at recombination junctions, with an overall decreased frequency of V(D)J recombination. Sequence analysis of VH-DH-JH junctions from the IgM locus in B-cell lines from ADA-deficient patients demonstrated an increase in A-T insertions equivalent to that found in the transfected cells. In contrast, elevation of dGTP pools, as would occur in PNP deficiency, did not alter the already rich G-C content of N regions. We conclude that the frequency of V(D)J recombination and the composition of N-insertions are influenced by increases in dATP levels, potentially leading to alterations in antigen receptors and aberrant lymphoid development. Alterations in N-region insertions may contribute to the B-cell dysfunction associated with ADA deficiency.

MeSH Terms
Adenosine Deaminase/deficiency Adenosine Deaminase Inhibitors Adenosine Triphosphate/metabolism Cells, Cultured DNA Nucleotidylexotransferase/metabolism Deoxyadenosines/pharmacology Deoxyguanine Nucleotides/metabolism Deoxyribonucleotides/metabolism Gene Rearrangement, B-Lymphocyte Humans Immunoglobulin M/genetics Purine-Pyrimidine Metabolism, Inborn Errors/enzymology Recombination, Genetic Sequence Analysis, DNA
Chemicals
Adenosine Deaminase Inhibitors Deoxyadenosines Deoxyguanine Nucleotides Deoxyribonucleotides Immunoglobulin M deoxyguanosine triphosphate Adenosine Triphosphate DNA Nucleotidylexotransferase Adenosine Deaminase 2'-deoxyadenosine
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Gangi-Peterson L
Curriculum in Genetics and Molecular Biology, Department of Pharmacology, University of North Carolina-Chapel Hill, North Carolina 27599, USA.
Sorscher D H
Reynolds J W
Kepler T B
Mitchell B S
References (40)
40 references, click to expand
  1. Unequal signal and coding joint formation in human V(D)J recombination.
    Mol Cell Biol. 1993 Jul;13(7):3900-6 PMID: 8321197
  2. Interdependence of N nucleotide addition and recombination site choice in V(D)J rearrangement.
    J Immunol. 1996 Nov 15;157(10):4451-7 PMID: 8906821
  3. Lack of N regions in antigen receptor variable region genes of TdT-deficient lymphocytes.
    Science. 1993 Aug 27;261(5125):1171-5 PMID: 8356451
  4. Mice lacking TdT: mature animals with an immature lymphocyte repertoire.
    Science. 1993 Aug 27;261(5125):1175-8 PMID: 8356452
  5. High-throughput purification of M13 templates for DNA sequencing.
    Biotechniques. 1993 Sep;15(3):414-6, 418-20, 422 PMID: 8217153
  6. Isolation and characterization of the Xenopus terminal deoxynucleotidyl transferase.
    J Immunol. 1994 May 1;152(9):4500-7 PMID: 8157965
  7. Mutational analysis of residues in the nucleotide binding domain of human terminal deoxynucleotidyl transferase.
    J Biol Chem. 1994 Apr 22;269(16):11859-68 PMID: 8163485
  8. Deoxyadenosine triphosphate as a potentially toxic metabolite in adenosine deaminase deficiency.
    Proc Natl Acad Sci U S A. 1978 Jan;75(1):472-6 PMID: 272665
  9. Purinogenic immunodeficiency diseases. Differential effects of deoxyadenosine and deoxyguanosine on DNA synthesis in human T lymphoblasts.
    J Clin Invest. 1979 Nov;64(5):1475-84 PMID: 115901
  10. Biochemical properties of purified human terminal deoxynucleotidyltransferase.
    J Biol Chem. 1980 May 10;255(9):4206-12 PMID: 7372675
  11. Joining of immunoglobulin heavy chain gene segments: implications from a chromosome with evidence of three D-JH fusions.
    Proc Natl Acad Sci U S A. 1982 Jul;79(13):4118-22 PMID: 6287467
  12. Mechanism of deoxyadenosine and 2-chlorodeoxyadenosine toxicity to nondividing human lymphocytes.
    J Clin Invest. 1985 Feb;75(2):377-83 PMID: 2579098
  13. DNA elements are asymmetrically joined during the site-specific recombination of kappa immunoglobulin genes.
    Science. 1985 May 10;228(4700):677-85 PMID: 3158075
  14. Inhibition of DNA repair by deoxyadenosine in resting human lymphocytes.
    J Immunol. 1986 Apr 15;136(8):2839-43 PMID: 2870121
  15. Extrachromosomal DNA substrates in pre-B cells undergo inversion or deletion at immunoglobulin V-(D)-J joining signals.
    Cell. 1987 Jun 19;49(6):775-83 PMID: 3495343
  16. Interaction of terminal transferase with single-stranded DNA.
    J Biol Chem. 1987 Jul 15;262(20):9494-502 PMID: 3597421
  17. Initiator role of double stranded DNA in terminal transferase catalyzed polymerization reactions.
    Nucleic Acids Res. 1988 Apr 11;16(7):2943-57 PMID: 3368312
  18. Lymphoid V(D)J recombination: nucleotide insertion at signal joints as well as coding joints.
    Proc Natl Acad Sci U S A. 1988 Nov;85(22):8588-92 PMID: 2847166
  19. Comparison of filler DNA at immune, nonimmune, and oncogenic rearrangements suggests multiple mechanisms of formation.
    Mol Cell Biol. 1989 Jul;9(7):3049-57 PMID: 2550794
  20. Enzymatic assay for deoxyribonucleoside triphosphates using synthetic oligonucleotides as template primers.
    Anal Biochem. 1989 Aug 1;180(2):222-6 PMID: 2554751
  21. Junctional sequences of T cell receptor gamma delta genes: implications for gamma delta T cell lineages and for a novel intermediate of V-(D)-J joining.
    Cell. 1989 Dec 1;59(5):859-70 PMID: 2590942
  22. RAG-1 and RAG-2, adjacent genes that synergistically activate V(D)J recombination.
    Science. 1990 Jun 22;248(4962):1517-23 PMID: 2360047
  23. Mutations induced at the hypoxanthine-guanine phosphoribosyltransferase locus of human T-lymphoblasts by perturbations of purine deoxyribonucleoside triphosphate pools.
    Cancer Res. 1990 Aug 1;50(15):4566-71 PMID: 2369732
  24. Adenosine deaminase deficiency.
    Immunodefic Rev. 1990;2(3):175-98 PMID: 2078332
  25. Three lymphoid-specific factors account for all junctional diversity characteristic of somatic assembly of T-cell receptor and immunoglobulin genes.
    Proc Natl Acad Sci U S A. 1992 Apr 1;89(7):2799-803 PMID: 1557386
  26. Antibody responses to bacteriophage phi X174 in patients with adenosine deaminase deficiency.
    Blood. 1992 Sep 1;80(5):1163-71 PMID: 1387561
  27. Overview of biochemical abnormalities and molecular genetics of adenosine deaminase deficiency.
    Pediatr Res. 1993 Jan;33(1 Suppl):S35-41 PMID: 8433873
  28. Impairment of V(D)J recombination in double-strand break repair mutants.
    Science. 1993 Apr 9;260(5105):207-10 PMID: 8469973
  29. Extent to which homology can constrain coding exon junctional diversity in V(D)J recombination.
    Nature. 1993 Jun 17;363(6430):625-7 PMID: 8510753
  30. The mechanism of V(D)J joining: lessons from molecular, immunological, and comparative analyses.
    Adv Immunol. 1994;56:27-150 PMID: 8073949
  31. Defective DNA-dependent protein kinase activity is linked to V(D)J recombination and DNA repair defects associated with the murine scid mutation.
    Cell. 1995 Mar 10;80(5):813-23 PMID: 7889575
  32. Initiation of V(D)J recombination in a cell-free system.
    Cell. 1995 Jun 16;81(6):925-34 PMID: 7781069
  33. T-cell specific avian TdT: characterization of the cDNA and recombinant enzyme.
    Nucleic Acids Res. 1995 Jun 11;23(11):2041-8 PMID: 7596835
  34. Formation and resolution of double-strand break intermediates in V(D)J rearrangement.
    Genes Dev. 1995 Oct 1;9(19):2409-20 PMID: 7557392
  35. Cleavage at a V(D)J recombination signal requires only RAG1 and RAG2 proteins and occurs in two steps.
    Cell. 1995 Nov 3;83(3):387-95 PMID: 8521468
  36. New insights into V(D)J recombination and its role in the evolution of the immune system.
    Immunity. 1995 Nov;3(5):531-9 PMID: 7584143
  37. Menage à trois: double strand break repair, V(D)J recombination and DNA-PK.
    Bioessays. 1995 Nov;17(11):949-57 PMID: 8526889
  38. Mechanistic constraints on diversity in human V(D)J recombination.
    Mol Cell Biol. 1996 Jan;16(1):258-69 PMID: 8524303
  39. The XRCC4 gene encodes a novel protein involved in DNA double-strand break repair and V(D)J recombination.
    Cell. 1995 Dec 29;83(7):1079-89 PMID: 8548796
  40. Coding end sequence can markedly affect the initiation of V(D)J recombination.
    Genes Dev. 1993 Jul;7(7B):1459-69 PMID: 8330743
Article Info
Journal
The Journal of clinical investigation
Abbr.
J Clin Invest
ISSN
0021-9738
Published
1999-03-00
Pages
833-41
Language
English
Region
United States
NLM ID
7802877
PMCID
PMC408138
Subset
IM
Grants
NCI NIH HHS · R01 CA034085 · United States
NCI NIH HHS · R0-1-CA34085 · United States
NCI NIH HHS · R29-CA67156 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com